Vig B K
Cancer Res. 1978 Mar;38(3):550-5.
When human leukocytes are treated with adriamycin (ADR) for brief durations of 1 to 2 hr at concentrations ranging between 0.04 and 0.25 microgram/ml, a dramatic reduction is observed in the frequency of chromosome aberrations in cells treated at 4 degrees in comparison to those treated at 37 degrees. Conversely, a severalfold increase in the frequency of aberrations is found if temperature at the time of ADR treatment is raised to 43 degrees. At higher temperatures, the most dramatic increase is in the frequency of exchanges. These results point to a parallelism between these studies and those carried out previously for determining cell death with hyperthermia and ADR treatment. This effect on chromosome aberrations appears only if temperatures of 4 of 43 degrees are applied during the period of exposure of cells to ADR. No effect is evident if cells are posttreated at 4 or 43 degrees after ADR is removed from the medium. The question of true synergism versus "facilitation" of influx of ADR into cells is discussed in light of the information obtained by other workers on total quantities of the drug present in the cell.
当人类白细胞在浓度为0.04至0.25微克/毫升的阿霉素(ADR)作用下处理1至2小时的短时间时,与在37℃处理的细胞相比,在4℃处理的细胞中观察到染色体畸变频率显著降低。相反,如果将ADR处理时的温度升至43℃,则畸变频率会增加几倍。在较高温度下,最显著的增加是交换频率。这些结果表明这些研究与先前进行的关于热疗和ADR治疗导致细胞死亡的研究之间存在平行关系。这种对染色体畸变的影响仅在细胞暴露于ADR期间施加4℃或43℃的温度时才会出现。如果在从培养基中去除ADR后在4℃或43℃对细胞进行后处理,则没有明显影响。根据其他研究人员获得的关于细胞中药物总量的信息,讨论了ADR流入细胞的真正协同作用与“促进作用”的问题。